Iran’s Medicine Crisis: Pharmacies Run Dry, Prices Skyrocket, and Health in Peril

The ongoing healthcare crisis in Iran has reached alarming levels, impacting millions of citizens who are struggling with severe shortages of essential drugs. Factors such as sanctions, widespread corruption, and the regime’s misplaced priorities have significantly crippled the healthcare system. This grim situation highlights a critical need for urgent reform and intervention.

Reports from the Iranian Nurses’ Association indicate that the healthcare crisis is exacerbated by a shortage of nursing staff, with many patients reportedly dying due to inadequate medical care. Furthermore, the pharmaceutical sector is experiencing its own catastrophic challenges. Pharmacies that once bustled with patients purchasing necessary medications are now facing empty shelves and desperate customers returning home without the treatment they need.

Despite statements from the Ministry of Health claiming that “90 percent of pharmaceutical currency needs have been met,” the ground reality tells a different story. The situation is characterized by skyrocketing drug prices, shrinking supplies, and a devastating decline in the purchasing power of ordinary Iranians.

Sanctions Exemptions but Deepening Shortages

While medications are technically exempt from U.S. and European sanctions, the availability and affordability of many essential drugs have deteriorated significantly in recent years. What initially began as a shortage of specialized medications has now expanded to include common, vital drugs such as:

• Painkillers
• Antibiotics
• Nutritional supplements

Last year, officials assured that drug prices would remain stable. However, both experts and pharmacies report a sharp increase in costs and a widening gap between supply and demand. Members of Parliament have acknowledged that the elimination of preferential exchange rates for pharmaceuticals has led to price increases of up to **400 percent** for vital medicines. Surveys reveal that “three out of every ten customers leave pharmacies empty-handed,” a stark indicator of the crisis.

Vital Supplements Out of Reach

The crisis has also extended to basic supplements, including:

• Omega-3
• Vitamin B12
• Multivitamins

These supplements are critical for preventing malnutrition and are not covered by insurance, leading to skyrocketing prices. For instance, the cost of a vitamin B12 injection has surged by over **228 percent** in a short time. Official data from the Ministry of Health indicates that **one in every three deaths** in Iran is linked to malnutrition-related complications, underscoring the severe human toll of these shortages.

Beyond Mismanagement: The Regime’s Costly Priorities

The roots of Iran’s medicine crisis run deeper than mere mismanagement or corruption. The regime’s focus on military, nuclear, and proxy policies has subjected the country to some of the toughest banking and financial sanctions globally. The recent activation of UN “snapback” sanctions has further worsened the situation, as Tehran directs much of its limited foreign currency reserves toward military expenditures rather than healthcare or social welfare.

Despite these challenges, regime leaders, including **Ali Khamenei**, **Abbas Araghchi**, and President **Masoud Pezeshkian**, have publicly downplayed the impact of renewed sanctions, claiming their economic effects are “minimal.”

The Economic Fallout

The pro-government newspaper **Etemad** recently reported that the snapback mechanism has led to significant disruptions in pharmaceutical banking and insurance transactions. **Mojtaba Sarkandi**, a veteran in the drug manufacturing sector, has warned of impending production shutdowns and severe shortages by the end of the year. He noted that financial sanctions have dramatically **increased** both the cost and time required to import raw materials, pushing many pharmaceutical companies toward bankruptcy.

Empty Shelves and Desperate Choices

According to the latest parliamentary data, between **150 and 165 essential drugs** have become scarce or unavailable in the last two years. Pharmacies across Iran report severe shortages of:

• Insulin
• Kidney medications
• Hormone therapies
• Basic nutritional supplements

Even everyday items like multivitamins and pain relief tablets have become increasingly difficult to find. The crisis has escalated to the point where many Iranians must choose between food and medicine, a heartbreaking reality for countless families. Vulnerable populations, such as the elderly and patients with chronic illnesses, are among the first victims of this collapse.

Dr. Ahmadi, a medical specialist, shared with the **Fararu** news outlet, “When patients stop treatment because they can’t afford it, their illnesses worsen, hospitalization costs rise, and the entire healthcare system faces a deeper crisis.”

The price of flu vaccines, which are critical as winter approaches, has also skyrocketed. Reports indicate that a French-made flu shot now costs around **2 million tomans**, while a Dutch version is priced at nearly **900,000 tomans**, despite regulations designed to control pricing. The lack of oversight has contributed to a growing black market for essential medications.

A Public Health Emergency

The medicine crisis in Iran has evolved beyond a mere healthcare issue; it has become a national emergency that reveals the consequences of the regime’s policies. As the government continues to allocate funds to missile programs, clerical institutions, and foreign militias, millions of Iranians are left without access to lifesaving drugs.

The empty shelves of pharmacies across Iran serve as stark symbols of a system that has prioritized political and ideological goals over the health and dignity of its people. Urgent action is needed to address this crisis and restore access to essential healthcare services for all citizens.